MYRIAD GENETICS INC
S-3, EX-23.1, 2000-09-14
COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Previous: MYRIAD GENETICS INC, S-3, EX-5.1, 2000-09-14
Next: PERRY ELLIS INTERNATIONAL INC, 10-Q, 2000-09-14



<PAGE>

                                                                    Exhibit 23.1

                        Consent of Independent Auditors

The Board of Directors
Myriad Genetics, Inc.

We consent to incorporation by reference in the registration statement on Form
S-3 of Myriad Genetics, Inc. of our report dated August 22, 2000, related to
the consolidated balance sheets of Myriad Genetics, Inc. and subsidiaries as of
June 30, 2000 and 1999 and the related consolidated statements of operations,
stockholders' equity and comprehensive loss and cash flows for each of the years
in the three-year period ended June 30, 2000, which report appears in the June
30, 2000 annual report on Form 10-K of Myriad Genetics, Inc., and the reference
to our firm under the heading "Experts" in the registration statement.

                                   KPMG LLP

Salt Lake City, Utah.
September 13, 2000



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission